Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event.

Avicel® PH LN reduces nitrosamine formation risks in oral solid dosages, ensuring compliance with Japan’s stringent regulatory standards. IFF Pharma Solutions expands its low-nitrite excipient ...

IFF is again looking to make 'bolt-on' acquisitions after digesting two large and expensive transactions. For now, though, it's spinning out a pharma unit. Chemicals giant International Flavors ...

IFF (NYSE: IFF) Pharma Solutions is excited to ... GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™ in hall 4 at booth 4F25, May 20-22, at the Fira Barcelona ...